Rule 16 Jun 2025 compliance, aviation, faa, airspace regulation, nappanee

✈️Amendment of Class E Airspace in Nappanee, IN

This action amends the Class E airspace at Nappanee, IN, and updates the geographic coordinates of the Nappanee Municipal Airport, Nappanee, IN, to coincide with the FAA's aeronautical database. This action is the result of an airspace review conducted due to the decommissioning of the Goshen very high frequency omnidirectional range (VOR) as part of the VOR Minimum Operational Network (MON) Program. It brings the airspace into compliance with FAA orders and supports instrument flight rule (IFR) procedures and operations.

Learn More
Notice 16 Jun 2025 regulation, health, public health, data collection, cdc

📊CDC Proposes Data Collection Extension for Epidemic Investigations

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a request for extension of an approved information collection titled Emergency Epidemic Investigation Data Collections. CDC uses the information collected to identify prevention and control measures in response to outbreaks and other public health events.

Learn More
Notice 16 Jun 2025 commerce, antidumping, imports, trade regulation, mexico, pipe and tube

📦Antidumping Duty Review Results for Light-Walled Pipe and Tube

The U.S. Department of Commerce (Commerce) determines that light-walled rectangular pipe and tube (LWRPT) from Mexico was sold in the United States at less than normal value during the period of review (POR), August 1, 2022, through July 31, 2023.

Learn More
Notice 16 Jun 2025 regulatory compliance, public comment, fda, pharmaceutical industry, biologics, cancer treatment

💊FDA Notice for Oncologic Drugs Advisory Committee Meeting

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.

Learn More
Notice 16 Jun 2025 compliance, department of commerce, economic analysis, business reporting, foreign investment, bea

📊Bureau of Economic Analysis Direct Investment Surveys Comment Request

The Department of Commerce, in accordance with the Paperwork Reduction Act of 1995 (PRA), invites the general public and other Federal agencies to comment on proposed, and continuing information collections, which helps us assess the impact of our information collection requirements and minimize the public's reporting burden. The purpose of this notice is to allow for 60 days of public comment preceding submission of the collection to OMB.

Learn More
Notice 16 Jun 2025 grant opportunities, national science foundation, entrepreneurship, technology commercialization, innovation corps

🚀NSF Innovation Corps

Under the Paperwork Reduction Act of 1995, and as part of its continuing effort to reduce paperwork and respondent burden, the National Science Foundation (NSF) is inviting the general public or other Federal agencies to comment on this proposed continuing information collection.

Learn More
Notice 16 Jun 2025 government, health, biomedical, licensing, innovation

🧬Government-Owned Inventions Available for Licensing in Biomedical Research

The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally funded research for the benefit of the public health.

Learn More
Notice 16 Jun 2025 fda, regulatory review, pharmaceutical, patent extension, vowst

💊FDA Issues Regulatory Review Period for VOWST Patent Extension

The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for VOWST and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.

Learn More
Notice 16 Jun 2025 compliance, hhs, public health, youth, data collection, cdc, tobacco

📊Proposed Data Collection for Youth Tobacco Survey by CDC

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Youth Tobacco Survey (NYTS) 2024-2026. NYTS provides national estimates of tobacco use behaviors, information about exposure to pro- and anti-tobacco influences, and information about racial and ethnic disparities in tobacco-related topics is the most comprehensive source of nationally representative tobacco data among students in grades 9-12, and is the only source of data for students in grades 6-8.

Learn More
Notice 16 Jun 2025 regulation, fda, pharmaceutical, patent extension, xolremdi, human drug products

💊FDA Notice on Regulatory Review Period for XOLREMDI Patent Extension

The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for XOLREMDI and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.

Learn More